HealthQuill Ophthalmology
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to 49 nations in Africa.
Drugs Health Pharma

Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA

Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.

Read More
The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal and harmful ophthalmic products.
Health Medical Pharma

FDA warns 8 firms for marketing harmful eye products 

HQ Team September 12, 2023: The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal.

Read More
Viatris acquisition
Drugs Health Pharma

Viatris acquires two companies for $750 million to sharpen ophthalmology vision

Viatris acquires two companies for $750 million to fuel ophthalmology vision

Read More